Browsing: Covid-19

In this 2026 midterm election season, health care ranks third on voters’ minds. That’s no surprise: U.S. life expectancy persistently lags those in comparable countries despite substantially greater spending on health care. As health and health care become increasingly political, we asked whether the leading drivers of mortality looked different by political geography in the…

An update on Invivyd, the small biotech company developing an injectable, low-dose monoclonal antibody to protect against Covid-19 infection like a vaccine does, but without the real or perceived limitations of vaccines. I last wrote about Invivyd in this newsletter in August 2025.